Israel - English - Ministry of Health

cts chemical industries ltd, israel - indomethacin - capsules - indomethacin 25 mg - indometacin - indometacin - non steroidal anti-inflammatory indicated for the active stages of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, degenerative joint disease of the hip, acute muscoloskeletal disorders, low back pain.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - valproic acid - capsules - valproic acid 200 mg - valproic acid - valproic acid - sole or adjunctive therapy in the treatment of simple (petit mal) and complex absence seizures. may also be used adjunctively in patients with multiple seizure types which include absence seizures.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - valproic acid - capsules - valproic acid 200 mg - valproic acid - valproic acid - sole or adjunctive therapy in the treatment of simple (petit mal) and complex absence seizures. may also be used adjunctively in patients with multiple seizure types which include absence seizures.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

natural wellness industries sdn. bhd. (milik penuh nutrivention sdn. bhd) - zinc oxide -

Israel - English - Ministry of Health

cts chemical industries ltd, israel - carbocisteine - capsules - carbocisteine 375 mg - carbocisteine - carbocisteine - treatment of disorders of the respiratory tract characterised by excessive or viscous mucus.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - cholesterol (unii: 97c5t2uq7j) (cholesterol - unii:97c5t2uq7j) - cholesterol 6 [hp_x] in 1 ml - for temporary relief of symptoms related to adrenal glands such as fatigue and low energy.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to adrenal glands such as fatigue and low energy.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

ironwood pharmaceuticals, inc. - lesinurad (unii: 09erp08i3w) (lesinurad - unii:09erp08i3w), allopurinol (unii: 63cz7gjn5i) (allopurinol - unii:63cz7gjn5i) - lesinurad 200 mg - duzallo®, a combination of lesinurad, a uric acid transporter 1 (urat1) inhibitor, and allopurinol, a xanthine oxidase inhibitor, is indicated for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a medically appropriate daily dose of allopurinol alone [see clinical studies (14) ]. duzallo is not recommended for the treatment of asymptomatic hyperuricemia. the use of duzallo is contraindicated in the following conditions: - severe renal impairment (eclcr less than 30 ml/min), end-stage renal disease, kidney transplant recipients, or patients on dialysis [see use in specific populations (8.6) ]. - tumor lysis syndrome or lesch-nyhan syndrome [see use in specific populations (8.8) ]. - known hypersensitivity to allopurinol, including previous occurrence of skin rash [see warnings and precautions (5.2) ]. risk summary there are no available human data on use of duzallo or lesinurad in pregnant women to inform a drug-associated risk of adverse

United States - English - NLM (National Library of Medicine)

ironwood pharmaceuticals, inc. - lesinurad (unii: 09erp08i3w) (lesinurad - unii:09erp08i3w) - lesinurad 200 mg - zurampic is indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone [see clinical studies (14) ]. zurampic is not recommended for the treatment of asymptomatic hyperuricemia. zurampic should not be used as monotherapy [see warnings and precautions (5.1) ]. the use of zurampic is contraindicated in the following conditions: - severe renal impairment (eclcr less than 30 ml/min), end stage renal disease, kidney transplant recipients, or patients on dialysis [see use in specific populations (8.6) ] - tumor lysis syndrome or lesch-nyhan syndrome [see use in specific populations (8.8) ]. risk summary there are no available human data on use of zurampic in pregnant women to inform a drug-associated risk. no teratogenicity or effects on fetal development were observed in embryo-fetal development studies with oral administration of lesinurad to pregnant rats

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sunzon international inc - aluminium phosphide - tablet (inc. pellet, bolus, suppository, capsule) - aluminium phosphide mineral-aluminium active 330.0 g/kg - insecticide - food product/commodity | grain handling machinery | shed,factory,warehouse or other building | stored barley seed | stored break - angoumois grain moth | bean weevil | cadelle | cigarette beetle | cockroach | coffee bean weevil | confused flour beetle | dried fruit beetle | flat grain beetle | granary weevil | hide or skin beetle | indian meal moth | lesser grain borer | maize weevil | mediterranean flour moth | merchant grain beetle | mottled grain moth | mouse - mus spp. | psocids or booklouse | raisin moth | rat | redlegged ham beetle | rice weevil | rust-red flour beetle | sawtoothed grain beetle | spider beetle | stored product mite | tobacco moth | tropical warehouse moth | warehouse beetle | dermestes ater | dermestes maculatus | grain borer | large cockroach | small cockroach | tobacco beetle

United States - English - NLM (National Library of Medicine)

cca industries, inc - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 2 ml in 100 ml